Carregant...
Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib
1. Vascular endothelial growth factor inhibitors (VEGFi) are known to cause hypertension and renal injury that severely limits their use as an anticancer therapy. We hypothesized that the angiotensin-converting enzyme inhibitor captopril not only prevents hypertension, but also decreases renal injur...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3613249/ https://ncbi.nlm.nih.gov/pubmed/22443474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1440-1681.2012.05699.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|